JP2015205894A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015205894A5 JP2015205894A5 JP2015111995A JP2015111995A JP2015205894A5 JP 2015205894 A5 JP2015205894 A5 JP 2015205894A5 JP 2015111995 A JP2015111995 A JP 2015111995A JP 2015111995 A JP2015111995 A JP 2015111995A JP 2015205894 A5 JP2015205894 A5 JP 2015205894A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- stro
- pharmaceutical composition
- composition according
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims description 18
- 210000000130 stem cell Anatomy 0.000 claims description 3
- 230000004069 differentiation Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 5
- 102100025683 Alkaline phosphatase, tissue-nonspecific isozyme Human genes 0.000 claims 2
- 101000574445 Homo sapiens Alkaline phosphatase, tissue-nonspecific isozyme Proteins 0.000 claims 2
- 208000001647 Renal Insufficiency Diseases 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 201000006370 kidney failure Diseases 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 210000005167 vascular cell Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19979608P | 2008-11-20 | 2008-11-20 | |
| US61/199,796 | 2008-11-20 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011536703A Division JP5891034B2 (ja) | 2008-11-20 | 2009-11-19 | 膵機能障害の治療または予防方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017112578A Division JP2017214384A (ja) | 2008-11-20 | 2017-06-07 | 膵機能障害の治療または予防方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015205894A JP2015205894A (ja) | 2015-11-19 |
| JP2015205894A5 true JP2015205894A5 (enExample) | 2019-02-28 |
| JP6499016B2 JP6499016B2 (ja) | 2019-04-10 |
Family
ID=42197754
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011536703A Active JP5891034B2 (ja) | 2008-11-20 | 2009-11-19 | 膵機能障害の治療または予防方法 |
| JP2015111995A Active JP6499016B2 (ja) | 2008-11-20 | 2015-06-02 | 膵機能障害の治療または予防方法 |
| JP2017112578A Withdrawn JP2017214384A (ja) | 2008-11-20 | 2017-06-07 | 膵機能障害の治療または予防方法 |
| JP2019162845A Active JP7051770B2 (ja) | 2008-11-20 | 2019-09-06 | 膵機能障害の治療または予防方法 |
| JP2021177234A Withdrawn JP2022031662A (ja) | 2008-11-20 | 2021-10-29 | 膵機能障害の治療または予防方法 |
| JP2023086994A Active JP7751607B2 (ja) | 2008-11-20 | 2023-05-26 | 膵機能障害の治療または予防方法 |
| JP2025099335A Pending JP2025148353A (ja) | 2008-11-20 | 2025-06-13 | 膵機能障害の治療または予防方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011536703A Active JP5891034B2 (ja) | 2008-11-20 | 2009-11-19 | 膵機能障害の治療または予防方法 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017112578A Withdrawn JP2017214384A (ja) | 2008-11-20 | 2017-06-07 | 膵機能障害の治療または予防方法 |
| JP2019162845A Active JP7051770B2 (ja) | 2008-11-20 | 2019-09-06 | 膵機能障害の治療または予防方法 |
| JP2021177234A Withdrawn JP2022031662A (ja) | 2008-11-20 | 2021-10-29 | 膵機能障害の治療または予防方法 |
| JP2023086994A Active JP7751607B2 (ja) | 2008-11-20 | 2023-05-26 | 膵機能障害の治療または予防方法 |
| JP2025099335A Pending JP2025148353A (ja) | 2008-11-20 | 2025-06-13 | 膵機能障害の治療または予防方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US8894972B2 (enExample) |
| EP (2) | EP2350266B1 (enExample) |
| JP (7) | JP5891034B2 (enExample) |
| KR (2) | KR102011609B1 (enExample) |
| CN (3) | CN104546912B (enExample) |
| AU (1) | AU2009317874B2 (enExample) |
| CA (1) | CA2744228C (enExample) |
| DK (1) | DK2350266T3 (enExample) |
| ES (2) | ES2550795T3 (enExample) |
| WO (1) | WO2010057260A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100111910A1 (en) * | 2006-07-12 | 2010-05-06 | Angioblast Systems, Inc. | Treatment of excessive neovascularization |
| KR102011609B1 (ko) * | 2008-11-20 | 2019-08-16 | 메소블라스트, 아이엔씨. | 췌장 기능장애를 치료 또는 예방하는 방법 |
| EP2898898B1 (en) | 2009-03-05 | 2025-09-10 | President and Fellows of Harvard College | Secreted AP2 and methods of inhibiting same |
| KR101871472B1 (ko) * | 2010-07-02 | 2018-06-27 | 메소블라스트, 아이엔씨. | 이식편대숙주 질환의 치료 방법 |
| SG194930A1 (en) | 2011-05-19 | 2013-12-30 | Mesoblast Inc | Methods for treating obesity and/or metabolic syndrome |
| CN109276706A (zh) * | 2011-06-03 | 2019-01-29 | 麦瑟布莱斯特公司 | 治疗或预防神经性疾病的方法 |
| WO2013003899A1 (en) * | 2011-07-04 | 2013-01-10 | Mesoblast, Inc | Methods of treating or preventing rheumatic disease |
| EP2729562B1 (en) | 2011-07-06 | 2018-04-18 | Cell Therapy Limited | Progenitor cells of mesodermal lineage |
| CN104098682B (zh) * | 2013-04-03 | 2018-01-02 | 苏州偲聚生物材料有限公司 | 多肽、包含该多肽的检测器件和检测试剂盒 |
| KR102506612B1 (ko) * | 2012-12-12 | 2023-03-06 | 메소블라스트, 아이엔씨. | 내피 기능장애 및 염증 질환의 치료 |
| US20140314872A1 (en) * | 2013-04-22 | 2014-10-23 | Hans Klingemann | Methods of Use of Culture Supernatant Obtained from Mesenchymal Stem Cells from Dogs and Cats for Treatment of Organ Dysfunction |
| CN104714021B (zh) * | 2013-12-12 | 2016-05-25 | 张曼 | 尿液凝血酶原蛋白在2型糖尿病合并冠心病中的应用 |
| BR112017023158A2 (pt) | 2015-04-30 | 2018-07-24 | Harvard College | anticorpos anti-ap2 e agentes de ligação de antígeno para tratar distúrbios metabólicos |
| EP3475299A4 (en) * | 2016-06-27 | 2020-03-18 | President and Fellows of Harvard College | CONNECTIONS FOR TREATING METABOLISM DISORDERS |
| CA3066733A1 (en) | 2017-06-09 | 2018-12-13 | President And Fellows Of Harvard College | Method to identify compounds useful to treat dysregulated lipogenesis, diabetes, and related disorders |
| CN110959579A (zh) * | 2019-11-14 | 2020-04-07 | 顾隽 | 患者来源的淋巴瘤免疫缺陷小鼠移植瘤模型的构建方法及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| WO1992001070A1 (en) | 1990-07-09 | 1992-01-23 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| DE69233013T2 (de) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
| AUPQ147799A0 (en) | 1999-07-07 | 1999-07-29 | Medvet Science Pty. Ltd. | Mesenchymal precursor cell |
| AU2003901668A0 (en) | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| DE19939781C2 (de) | 1999-08-21 | 2003-06-18 | Schott Glas | Skulltiegel für das Erschmelzen oder das Läutern von anorganischen Substanzen, insbesondere von Gläsern und Glaskeramiken |
| WO2004016747A2 (en) * | 2002-08-14 | 2004-02-26 | University Of Florida | Bone marrow cell differentiation |
| DE602004030823D1 (de) * | 2003-11-04 | 2011-02-10 | Biomaster Inc | Verfahren und system zur herstellung von stammzellen aus fettgewebe |
| US20080260694A1 (en) | 2004-09-24 | 2008-10-23 | Angioblast Systems, Inc. | Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof |
| KR101617319B1 (ko) * | 2005-04-12 | 2016-05-02 | 메소블라스트, 아이엔씨. | 조직 비특이적인 알카리 포스파타제에 의한 다분화성 성체 세포의 분리 |
| GB0514785D0 (en) * | 2005-07-19 | 2005-08-24 | Innovia Films Ltd | Sealed ream wrap package and films suitable for forming such packages |
| US20120027729A1 (en) * | 2006-04-28 | 2012-02-02 | Tulane University Health Sciences Center | Methods for treating diabetes |
| EP2117543A4 (en) * | 2007-02-01 | 2011-09-28 | Nephrogen Llc | POTENTIALIZATION OF THE IMPLANTATION OF STEM CELLS AND TREATMENT OF ORGAN DYSFUNCTION OR BODY INSUFFICIENCY |
| KR102011609B1 (ko) | 2008-11-20 | 2019-08-16 | 메소블라스트, 아이엔씨. | 췌장 기능장애를 치료 또는 예방하는 방법 |
| US9405700B2 (en) | 2010-11-04 | 2016-08-02 | Sonics, Inc. | Methods and apparatus for virtualization in an integrated circuit |
-
2009
- 2009-11-19 KR KR1020187004814A patent/KR102011609B1/ko active Active
- 2009-11-19 WO PCT/AU2009/001511 patent/WO2010057260A1/en not_active Ceased
- 2009-11-19 KR KR1020117012519A patent/KR101832497B1/ko active Active
- 2009-11-19 DK DK09827049.9T patent/DK2350266T3/en active
- 2009-11-19 AU AU2009317874A patent/AU2009317874B2/en active Active
- 2009-11-19 ES ES09827049.9T patent/ES2550795T3/es active Active
- 2009-11-19 EP EP09827049.9A patent/EP2350266B1/en active Active
- 2009-11-19 US US13/129,180 patent/US8894972B2/en active Active
- 2009-11-19 CN CN201410727242.0A patent/CN104546912B/zh active Active
- 2009-11-19 CN CN201310652234.XA patent/CN103800370B/zh active Active
- 2009-11-19 CA CA2744228A patent/CA2744228C/en active Active
- 2009-11-19 ES ES15178550.8T patent/ES2651503T3/es active Active
- 2009-11-19 EP EP15178550.8A patent/EP3002329B1/en active Active
- 2009-11-19 CN CN200980155054.2A patent/CN102307992B/zh active Active
- 2009-11-19 JP JP2011536703A patent/JP5891034B2/ja active Active
-
2014
- 2014-11-07 US US14/535,827 patent/US9480713B2/en active Active
-
2015
- 2015-06-02 JP JP2015111995A patent/JP6499016B2/ja active Active
-
2016
- 2016-10-27 US US15/336,234 patent/US9968640B2/en active Active
-
2017
- 2017-06-07 JP JP2017112578A patent/JP2017214384A/ja not_active Withdrawn
-
2019
- 2019-09-06 JP JP2019162845A patent/JP7051770B2/ja active Active
-
2021
- 2021-10-29 JP JP2021177234A patent/JP2022031662A/ja not_active Withdrawn
-
2023
- 2023-05-26 JP JP2023086994A patent/JP7751607B2/ja active Active
-
2025
- 2025-06-13 JP JP2025099335A patent/JP2025148353A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015205894A5 (enExample) | ||
| Xie et al. | Functional dental pulp regeneration: basic research and clinical translation | |
| Trubiani et al. | Human oral stem cells, biomaterials and extracellular vesicles: a promising tool in bone tissue repair | |
| Molnar et al. | Mesenchymal stem cell mechanisms of action and clinical effects in osteoarthritis: a narrative review | |
| Hernández-Monjaraz et al. | Mesenchymal stem cells of dental origin for inducing tissue regeneration in periodontitis: a mini-review | |
| Köhnke et al. | Temporomandibular joint osteoarthritis: regenerative treatment by a stem cell containing advanced therapy medicinal product (ATMP)—An In Vivo Animal Trial | |
| Stellavato et al. | Hybrid complexes of high and low molecular weight hyaluronans highly enhance HASCs differentiation: implication for facial bioremodelling | |
| de Bakker et al. | Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man | |
| Chang et al. | Multi-therapeutic effects of human adipose-derived mesenchymal stem cells on radiation-induced intestinal injury | |
| Smojver et al. | Mesenchymal stem cells based treatment in dental medicine: a narrative review | |
| Guan et al. | Mesenchymal stem cells in the tumor microenvironment | |
| PH12017502181A1 (en) | Nutritional compositions containing an elevated level of inositol and uses thereof | |
| Sugiaman et al. | Tissue engineering with stem cell from human exfoliated deciduous teeth (SHED) and collagen matrix, regulated by growth factor in regenerating the dental pulp | |
| Xu et al. | Roles of cartilage-resident stem/progenitor cells in cartilage physiology, development, repair and osteoarthritis | |
| EA201490032A1 (ru) | Лиофилизированные препараты fgf-18 | |
| Song et al. | Mesenchymal stromal cells in osteoarthritis: evidence for structural benefit and cartilage repair | |
| EA201790950A1 (ru) | Способы и композиции, в частности, для лечения синдрома дефицита внимания | |
| Liu et al. | The involving roles of intrahepatic and extrahepatic stem/progenitor cells (SPCs) to liver regeneration | |
| RU2014146291A (ru) | Способ использования сложных эфиров азелаиновой кислоты для модуляции передачи сигналов, медиируемых биологическими молекулами | |
| Mohd Nor et al. | From teeth to therapy: a review of therapeutic potential within the secretome of stem cells from human exfoliated deciduous teeth | |
| EA201690005A1 (ru) | Состав с модифицированной кинетикой высвобождения | |
| Cullier et al. | Functionalized nanogels with endothelin-1 and bradykinin receptor antagonist peptides decrease inflammatory and cartilage degradation markers of osteoarthritis in a horse organoid model of cartilage | |
| Ning et al. | Microfiber-reinforced composite hydrogels loaded with rat adipose-derived stem cells and BMP-2 for the treatment of medication-related osteonecrosis of the jaw in a rat model | |
| Di Vito et al. | A review of novel strategies for human periodontal ligament stem cell ex vivo expansion: are they an evidence-based promise for regenerative periodontal therapy? | |
| Svoradova et al. | Chicken mesenchymal stem cells and their applications: a mini review |